Peddock Capital Advisors’s Akoya BioSciences AKYA Stock Holding History

Peddock Capital Advisors’s Portfolio AKYA Stock Details AKYA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-234,720	Closed	-$305K	–	162
2025 Q2	$305K	Hold	234,720	–	–	0.07%	131
2025 Q1	$326K	Hold	234,720	–	–	0.08%	129
2024 Q4	$538K	Hold	234,720	–	–	0.13%	99
2024 Q3	$638K	Sell	234,720 -206	-0.1%	-$503	0.15%	97
2024 Q2	$550K	Sell	234,926 -5,124	-2%	-$16.3K	0.14%	100
2024 Q1	$1.13M	Sell	240,050 -50,670	-17%	-$263K	0.3%	75
2023 Q4	$1.42M	Buy	290,720 +245,728	+546%	+$1.02M	0.43%	57
2023 Q3	$209K	Buy	44,992 +14,992	+50%	+$86.2K	0.07%	138
2023 Q2	$222K	Buy	+30,000	New	+$200K	0.07%	137

Peddock Capital Advisors's AKYA Position: Q3 2025 in Review

Peddock Capital Advisors sold out of Akoya BioSciences (AKYA) in Q3 2025, closing a stake of 234,720 shares — an estimated $305K sold.

Peddock Capital Advisors first reported a position in AKYA in Q2 2023 and held it in 9 quarters. The position peaked at $1.42M in Q4 2023. 0 funds tracked by Wall St. Rank hold AKYA as of Q3 2025.

Peddock Capital Advisors reported no remaining Akoya BioSciences position as of Q3 2025 after selling out during the quarter.
Peddock Capital Advisors sold 234,720 Akoya BioSciences shares in Q3 2025, an estimated $305K.
Peddock Capital Advisors first reported a position in Akoya BioSciences in Q2 2023 and held it in 9 quarters.
Peddock Capital Advisors's Akoya BioSciences position peaked at $1.42M in Q4 2023.
0 funds tracked by Wall St. Rank held Akoya BioSciences as of Q3 2025.

Based on Peddock Capital Advisors's 13F filing for Q3 2025, filed 17 Oct 2025.